Panbela Therapeutics Inc - ESG Rating & Company Profile powered by AI
This SDG score for Panbela Therapeutics Inc indicates its reporting of the UN Sustainable Development Goals. Alternative corporations in the rating industry group for Panbela Therapeutics Inc are shown. This page displays a zero-cost E,S&G report for Panbela Therapeutics Inc.
Panbela Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 8.0, social score of 5.3 and governance score of 5.3.
6.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 427 | Scancell Holdings PLC | 6.3 | High |
| 427 | Verastem Inc | 6.3 | High |
| 450 | Panbela Therapeutics Inc | 6.2 | High |
| 450 | Cannasouth Ltd | 6.2 | High |
| 450 | CareDx International AB | 6.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Panbela Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Panbela Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Panbela Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Panbela Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Panbela Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Panbela Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Panbela Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Panbela Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Panbela Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Panbela Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Panbela Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Panbela Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Panbela Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Panbela Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Panbela Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Panbela Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Panbela Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Panbela Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.